NCT06714773Completed
Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs Resection
Source: ClinicalTrials.gov · Last updated 4 Dec 2024
Brief summary (registry, in English)
The goal of this observational study is to assess the oncological outcomes in patients diagnosed with grade 2 chondrosarcoma, treated with intralesional curettage, stratified into two cohorts: those subjected to follow up monitoring and those who have undergone subsequent surgical intervention.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 62 (actual)
- First submitted
- 28 Nov 2024
- Start date
- 20 Jan 2024
- Primary completion date
- 20 Jul 2024
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Sarcoma
- NCT number
- NCT06714773
What you commit to
- Study type: Observational
- Participants enrolled: 62
- From 20 Jan 2024 to the primary completion date, 20 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients undergoing wide resection as the primary treatment.
Other
- Patients diagnosed with grade 1 or 3 chondrosarcoma on the histological diagnosis of the operative specimen.
- Patients with less than 12 months follow-up.
Who the study is looking for
- Patients with a diagnosis of grade 2 chondrosarcoma of the appendiceal skeleton in the definitive specimen;
- Patients treated with intralesional curettage surgery;
- Patients aged \>=18 years;
- Patients who were treated between 01/01/2008 and 31/12/2020.
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna Coordinator of this site? Confirm its status | Bologna | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.